دورية أكاديمية

Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial

التفاصيل البيبلوغرافية
العنوان: Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial
المؤلفون: Melani, Christopher, Dowdell, Kennichi, Pittaluga, Stefania, Dunleavy, Kieron, Roschewski, Mark, Song, Joo Y, Calattini, Sara, Kawada, Jun-ichi, Price, David A, Chattopadhyay, Pratip K, Roederer, Mario, Lucas, Andrea N, Steinberg, Seth M, Jaffe, Elaine S, Cohen, Jeffrey I, Wilson, Wyndham H *
المصدر: In The Lancet Haematology May 2023 10(5):e346-e358
قاعدة البيانات: ScienceDirect
الوصف
تدمد:23523026
DOI:10.1016/S2352-3026(23)00029-7